2023 Symposium Ad

About the Symposium

AAMA’s 2023 Annual Symposium


The American Academy of Medical Acupuncture has designed the Annual Symposium to meet an expressed need to explore the mechanisms of acupuncture from several different perspectives and to examine current scientific research in the field of medical acupuncture. It will address topics suggested by practitioners and stress a variety of approaches to practical clinical problems.

This symposium will present multi-faceted approaches for understanding, appreciating, and applying acupuncture in today’s practice. It will expand awareness of the scientific research into the effects of acupuncture, while enhancing understandings of classical wisdom.  It will help clinicians apply the medicine both towards direct patient care, and in overcoming care delivery challenges.


The Symposium is designed to provide individuals with a wide range of learning opportunities, activities, and experiences that will match their educational and professional development needs.


By the conclusion of the Symposium, participants should be able to:

  • Identify barriers and opportunities for the incorporation of acupuncture into existing medical practices, and recognize critical points in developing new practice models for acupuncture delivery;
  • Recognize acupuncture’s role in treatment options for acute and chronic pain syndromes of many types, and apply to various clinical cases;
  • Discuss the modern evidence base for acupuncture’s mechanisms of action, and recognize how these mechanisms interface with classical and modern treatment strategies.

Continuing Education Credits

The American Academy of Medical Acupuncture is accredited by the Accreditation Council for Continuing Medical education to provide continuing medical education for physicians.

The AAMA designates this live activity (Symposium) for a maximum of 21.5 AMA PRA Category 1 Credits™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The AAMA designates this live activity (each Pre-Symposium workshop) for a maximum of 7.5 AMA PRA Category 1 Credits™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NCCAOM PDA Provider # 173327
29 PDAs Available

Disclosure Information

In accordance with the ACCME Accreditation Criteria, the American Academy of Medical Acupuncture must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions).

Ineligible Company

The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.

Financial Relationships

Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.

Conflict of Interest

Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.

The ACCME also requires that AAMA manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.

Symposium Information

2023 Symposium Planning Committee

  • Jennifer Dilts, DO, DABMA, Chair
  • David Coggin-Carr, MD, PhD, DABMA, Vice-Chair
  • Timothy Carman, MD
  • Stephanie Cheng, MD, FAAMA
  • Valerie Ebel, MD
  • Jessica Haloskie, MD, DABMA
  • Sachiko Kaizuka, MD, DABMA
  • Yuan-Chi Lin, MD, FAAMA
  • Demetrios Papadopoulos, MD, FAAMA
  • Kathryn Peeden, MD, DABMA
2023SympBrochure Cover

Want an overview about the exciting education-packed 5 days in Dallas, TX?


COVID & Meeting Safety Disclaimer

By registering for this meeting, participants acknowledge that they recognize the risks associated with attending and interacting with meeting attendees, staff, and others while participating in the AAMA Annual Symposium. Individuals exhibiting symptoms of COVID-19 as defined by the CDC are prohibited from attending the meeting. By registering for this meeting, I acknowledge that AAMA is not liable for the spread or transfer of any virus, illness or injury for me or any of my guests as a result of attending the AAMA Annual Symposium.

Participants also acknowledge that participation in demonstrations or practical exercises during the meeting is voluntary and at participant’s own risk. By registering, you agree and understand requirements and potential risks with your participation.

Please be mindful of continuing Covid-19 precautions.  Also, mindful social distancing is encouraged. Self assessment is encouraged – if you are not feeling well, do not participate. We will continue to monitor developments and revise these protocols as necessary closer to the meeting.

Have a suggestion or question about the Annual Symposium?EMAIL AAMA